An improved imaging agent for malignant melanoma, based on [Nle4,D-Phe7]alpha-melanocyte stimulating hormone.

Bard, D R

Bard, D R.

Affiliation

Bard DR; Strangeways Research Laboratory, Cambridge, UK.

Nucl Med Commun ; 16(10): 860-6, 1995 Oct.

Article in En | MEDLINE | ID: mdl-8570117

Subject(s)

Indium Radioisotopes; Melanoma, Experimental/diagnostic imaging; Pentetic Acid/analogs & derivatives; Amino Acid Sequence; Animals; Enzyme Activation/drug effects; Evaluation Studies as Topic; Indium Radioisotopes/pharmacokinetics; Male; Melanocyte-Stimulating Hormones/pharmacokinetics; Melanocyte-Stimulating Hormones/pharmacology; Melanoma, Experimental/enzymology; Mice; Mice, Inbred DBA; Molecular Sequence Data; Monophenol Monooxygenase/metabolism; Neoplasm Proteins/metabolism; Neoplasm Transplantation; Pentetic Acid/pharmacokinetics; Pentetic Acid/pharmacology; Radionuclide Imaging; Tissue Distribution; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / Indium Radioisotopes / Pentetic Acid Type of study: Diagnostic_studies / Evaluation_studies Limits: Animals Language: En Journal: Nucl Med Commun Year: 1995 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links